Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Machine Name

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Enhancing the prognostic accuracy of the RETREAT score with AFP-L3 and DCP tumor markers.

Read more about Enhancing the prognostic accuracy of the RETREAT score with AFP-L3 and DCP tumor markers.

The Liver Frailty Index enhances mortality risk prediction above and beyond MELD 3.0 alone.

Read more about The Liver Frailty Index enhances mortality risk prediction above and beyond MELD 3.0 alone.

Clinically relevant cut-points for changes in the Liver Frailty Index are associated with waitlist mortality in patients with cirrhosis.

Read more about Clinically relevant cut-points for changes in the Liver Frailty Index are associated with waitlist mortality in patients with cirrhosis.

Caregivers' and providers' perspectives of social and medical care after pediatric liver transplant: Results from the multicenter SOCIAL-Tx study.

Read more about Caregivers' and providers' perspectives of social and medical care after pediatric liver transplant: Results from the multicenter SOCIAL-Tx study.

Cost-effectiveness analysis of interventional liver-directed therapies for downstaging of hepatocellular carcinoma before liver transplant.

Read more about Cost-effectiveness analysis of interventional liver-directed therapies for downstaging of hepatocellular carcinoma before liver transplant.

Geographic disparities in access to liver transplantation.

Read more about Geographic disparities in access to liver transplantation.

AFP-L3 and DCP are superior to AFP in predicting waitlist dropout in HCC patients: Results of a prospective study.

Read more about AFP-L3 and DCP are superior to AFP in predicting waitlist dropout in HCC patients: Results of a prospective study.

Serum and plasma protein biomarkers associated with frailty in patients with cirrhosis.

Read more about Serum and plasma protein biomarkers associated with frailty in patients with cirrhosis.

Costs of pediatric liver transplantation among commercially insured and Medicaid-insured patients with cholestasis in the US.

Read more about Costs of pediatric liver transplantation among commercially insured and Medicaid-insured patients with cholestasis in the US.

Alpha-fetoprotein slope over 7.5 ng/ml over 3 months before liver transplantation for hepatocellular carcinoma predicts recurrence even after controlling for alpha-fetoprotein at liver transplantation.

Read more about Alpha-fetoprotein slope over 7.5 ng/ml over 3 months before liver transplantation for hepatocellular carcinoma predicts recurrence even after controlling for alpha-fetoprotein at liver transplantation.

Subscribe to Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society